United Capital Financial Advisers, LLC Geron Corp Transaction History

United Capital Financial Advisers, LLC

  • $11.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$1.59 - $2.19 $32,610 - $44,916
-20,510 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$1.15 - $1.59 $218 - $302
190 Added 0.94%
20,510 $27,000
Q1 2019

May 14, 2019
BUY
$1.01 - $1.83 $3,030 - $5,490
3,000 Added 17.32%
20,320 $34,000
Q3 2018

Nov 14, 2018
BUY
$1.76 - $6.38 $30,483 - $110,501
17,320 New
17,320 $30,000

Others Institutions Holding GERN

# of Institutions
259
Shares Held
450M
Call Options Held
1.91M
Put Options Held
897K
View Full List

About GERON CORP

GERN Quotes by TradingView
  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.59B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email